SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-13-014886
Filing Date
2013-01-16
Accepted
2013-01-16 17:28:04
Documents
4
Period of Report
2013-01-16

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT d469192dpre14a.htm PRE 14A 145633
2 GRAPHIC g4691921.jpg GRAPHIC 93158
3 GRAPHIC g4691922.jpg GRAPHIC 80543
4 GRAPHIC g469192g95l79.jpg GRAPHIC 7061
  Complete submission text file 0001193125-13-014886.txt   396317
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-22873 | Film No.: 13533104
SIC: 2835 In Vitro & In Vivo Diagnostic Substances